Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Southwest Airlines
LUV
$21.7B
| $5.64M | ﹤0.01% |
167,892
-1,755,198
| -91% | -$56M |
|
3727
Cartesian Therapeutics
RNAC
$267M
| $5.64M | ﹤0.01% |
315,000
-60,767
| -16% | -$1.23M |
|
3728
CALL
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $5.64M | ﹤0.01% |
92,400
+1,800
| +2% | +$108K |
|
3729
Albany International
AIN
$1.84B
| $5.63M | ﹤0.01% |
70,444
-36,392
| -34% | -$2.86M |
|
3730
PUT
Church & Dwight Co
CHD
$24B
| $5.63M | ﹤0.01% |
53,800
+32,500
| +153% | +$3.43M |
|
3731
CALL
Winnebago Industries
WGO
$892M
| $5.63M | ﹤0.01% |
117,800
-91,700
| -44% | -$5.2M |
|
3732
PUT
Summit Therapeutics
SMMT
$10.6B
| $5.63M | ﹤0.01% |
315,300
-142,500
| -31% | -$2.76M |
|
3733
PUT
Noble Corp
NE
$7.2B
| $5.62M | ﹤0.01% |
178,895
+68,406
| +62% | +$2.26M |
|
3734
SunCoke Energy
SXC
$794M
| $5.61M | ﹤0.01% |
524,200
-187,269
| -26% | -$2.01M |
|
3735
CALL
uniQure
QURE
$3.37B
| $5.61M | ﹤0.01% |
317,400
+256,500
| +421% | +$2.21M |
|
3736
Timken Company
TKR
$9.25B
| $5.6M | ﹤0.01% |
78,521
+11,897
| +18% | +$935K |
|
3737
Indivior Pharmaceuticals
INDV
$4.6B
| $5.6M | ﹤0.01% |
450,796
+138,211
| +44% | +$1.42M |
|
3738
iShares Core MSCI EAFE ETF
IEFA
$196B
| $5.6M | ﹤0.01% |
+79,697
| New | +$5.88M |
|
3739
News Corp Class B
NWS
$17.9B
| $5.6M | ﹤0.01% |
184,027
-224,033
| -55% | -$6.76M |
|
3740
Global X Copper Miners ETF NEW
COPX
$7.98B
| $5.59M | ﹤0.01% |
146,478
+56,167
| +62% | +$2.43M |
|
3741
CALL
Watsco Inc
WSO
$12.9B
| $5.59M | ﹤0.01% |
11,800
-10,200
| -46% | -$5.17M |
|
3742
CALL
Levi Strauss
LEVI
$8.68B
| $5.59M | ﹤0.01% |
323,200
+15,500
| +5% | +$274K |
|
3743
AXIS Capital
AXS
$7.38B
| $5.59M | ﹤0.01% |
63,074
+30,475
| +93% | +$2.61M |
|
3744
CALL
Travelers Companies
TRV
$77.2B
| $5.59M | ﹤0.01% |
23,200
-74,200
| -76% | -$18.5M |
|
3745
American States Water
AWR
$3.53B
| $5.59M | ﹤0.01% |
71,890
-5,221
| -7% | -$435K |
|
3746
CALL
Bumble
BMBL
$358M
| $5.58M | ﹤0.01% |
685,800
+9,100
| +1% | +$70.2K |
|
|
PPLI
3747
PUT
People Inc
PPLI
$3.01B
| $5.58M | ﹤0.01% |
157,617
+83,502
| +113% | +$3.35M |
|
3748
PUT
Magna International
MGA
$18.8B
| $5.57M | ﹤0.01% |
133,400
-25,800
| -16% | -$1.11M |
|
3749
CALL
Magnite
MGNI
$3.55B
| $5.56M | ﹤0.01% |
349,300
-151,500
| -30% | -$2.22M |
|
3750
Vestis
VSTS
$1.76B
| $5.56M | ﹤0.01% |
364,652
+117,960
| +48% | +$1.78M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.